Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 6 (VAMAS6)

Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 6, also known as generalized vitiligo, is related to vitiligo-associated multiple autoimmune disease susceptibility 1 and deafness-vitiligo-achalasia syndrome, and has symptoms including exanthema and pruritus. An important gene associated with Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 6 is PTPN22 (Protein Tyrosine Phosphatase Non-Receptor Type 22). The drugs Travoprost and Fluticasone have been mentioned in the context of this disorder. Affiliated tissues include skin and t cells, and related phenotypes are vitiligo and nevus